It is noteworthy that these findings are similar to those of several rat studies, evidencing in the case of the BPC 157 therapy a consistent transfer of animal data [180,265,266,267,268]
Seattle, WA 98112 Phone: 206.347.4644 Fax: 206.480.1739 Hours: Mon-Fri: 9am-6pm Sat: 10am-6pm Sun: 11am-4pm
Treatment of Leber's optic atrophy
Liraglutide showed a 9% increased risk.
Common reactions may include: Nausea, especially after the first few doses Flushing or warmth in the face or chest Headache Mild injection site reactions such as redness or tenderness Nausea is the most commonly reported side effect, but it often decreases with continued use as the body adjusts
Interestingly, several of the new product listings on Amazon for BPC 157 appear to come from Alibaba sellers that offer bulk peptides available in pre-made packaging for anyone to put their brand on